Carregant...
TMOD-30. TARGETING AN OLIG2-DEPENDENT PATHWAY TO INHIBIT TUMOR GROWTH IN PRIMARY AND RECURRENT MEDULLOBLASTOMA
Medulloblastoma represents the most common childhood malignant brain tumor. Despite aggressive multimodal therapy, a significant proportion of surviving patients suffer from severe treatment-related side effects, including tumor relapse. Thus, there is an urgent need for novel therapeutic modalities...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692633/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1067 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|